On its face, Kenvue (NYSE: KVUE ) admittedly doesn't look like much right now. Organic revenue for the consumer health giant fell 2.7% year-over-year in the first half of the year. Guidance suggests minimal, if any, improvement in the secondI've been contributing to Seeking Alpha and other investment websites since 2011, with a general (though far from rigid) focus on value over growth. I got my Series 7 and 63 back in 1999, and watched the dot-com bubble peak and then burst in real time at a small, tech-fo ...